Tim Wilson

Tim Wilson serves as CEO at Epsilogen Ltd. Epsilogen Ltd operates in the biotechnology sector with approximately 28.0 employees. The company is headquartered in London, England. To date, Epsilogen Ltd has raised 59543815.0 in total funding, with the most recent round being Series B.

Industry & Role Insights

• • MessageCEO tracks 381 executives in the biotechnology sector.
• • 10,137 executive contacts are available in England.
• • Our database includes 201,468 c suite-level executives.

Outlook Microsoft Office 365 DigitalOcean Nginx Google Font API Google Analytics Apache reCAPTCHA Vimeo Google Tag Manager Mobile Friendly WordPress.org Render IoT Remote AI

ige antibodies oncology immune therapy mov18 ige immunoglobulin e solid tumors treatment clinical trials targeted therapy cancer immunotherapy tumor microenvironment folate receptor alpha ovarian cancer ige function igg platform cancer research anti-cancer therapies immunosurveillance macrophage infiltration t cell activation therapeutic antibodies patient recruitment phase trial safety & efficacy tissue half-life cancer treatment modalities hybrid antibodies nk cells activation immune evasion strong efficacy expanding clinical trials pro-inflammatory response tumor destruction antibody engineering cancer patient care research collaboration biomedical research novel therapeutics drug development biologics innovation clinical development life sciences pharmaceutical development immune system modulation tumor cell targeting platinum-resistant cancer medical innovation cancer-related technology translational medicine hospital & health care health care health wellness & fitness

CB

Chip Baird Chief Executive Officer at 2seventy bio at 2seventy bio

JL

Jason Loveridge CEO at 4SC AG

MM

Marie Moores Chief Operating Officer at AB Cavalli Coach & Consultant

JR

Julie Rubinstein President and Chief Operating Officer at Adaptive Biotechnologies Corp.

CH

Chris Harano President and CEO at Advanced BioCatalytics

Outreach Guidance — biotechnology Sector

Technology executives make decisions on infrastructure, tooling, and partnerships. When reaching out to Tim Wilson, lead with your value proposition relative to the stack they currently use. Generic pitches perform poorly; specific technical relevance is key.

Tim Wilson's Position in the MessageCEO Database

• •Tim Wilson is 1 of 1 verified executive contact we track at Epsilogen Ltd.
• •365 verified executive contacts in biotechnology are in the MessageCEO database.
• •10,040 verified executive contacts in England are in the database.
• •8 verified contacts work at biotechnology companies in the 28.0 employee range (same size as Epsilogen Ltd).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Tim Wilson directly?

Tim Wilson's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at Epsilogen Ltd. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Tim Wilson work for?

Tim Wilson is CEO at Epsilogen Ltd, a company in the biotechnology sector with 28.0 employees. The company is based in London, England.

Can I pitch or sell to Tim Wilson?

As CEO at Epsilogen Ltd, Tim Wilson is a key decision-maker in the biotechnology sector. MessageCEO Pro gives you verified email to reach Tim Wilson directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Tim Wilson in?

Tim Wilson works in the biotechnology industry as CEO at Epsilogen Ltd. MessageCEO provides verified contact information for executives across all major industries.

Is Tim Wilson's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Tim Wilson's profile is kept up-to-date with the latest available information.

Last updated: July 28, 2026